Skip to main content
OpenTrials

Clinical trial condition

Immunoglobulin Light-chain Amyloidosis

Explore clinical trials studying Immunoglobulin Light-chain Amyloidosis. Study availability and eligibility vary by location and protocol.

187 public trials 43 recruiting studies
Refine in advanced search Browse all conditions

Immunoglobulin Light-chain Amyloidosis trial results

Completed

Study of Oral Ixazomib in Adult Participants With Relapsed or Refractory Light Chain Amyloidosis

NCT01318902

Conditions
Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +10 more
Locations
  • Tufts Medical Center Boston, Massachusetts, United States
  • Boston Medical Center Boston, Massachusetts, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Completed

Bendamustine and Dexamethasone in Patients With Relapsed AL Amyloidosis

NCT01222260

Conditions
AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations
  • Tufts Medical Center Boston, Massachusetts, United States
  • Boston Medical Center Boston, Massachusetts, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Mt. Sinai Medical Center New York, United States
View Trial Details
Completed

Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies

NCT00014235

Conditions
Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, +159 more
Locations
  • University of Arizona Health Sciences Center Tucson, Arizona, United States
  • City of Hope Medical Center Duarte, California, United States
  • Stanford University Hospitals and Clinics Stanford, California, United States
  • OHSU Knight Cancer Institute Portland, Oregon, United States
View Trial Details
Completed

Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer

NCT00006251

Conditions
Acute Undifferentiated Leukemia, Adenocarcinoma, Adult Nasal Type Extranodal NK/T-cell Lymphoma, +152 more
Locations
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
  • University of Torino Torino, Italy
View Trial Details
Completed

The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis

NCT02632786

Conditions
AL Amyloidosis, Alzheimer Disease, Amyloidosis, +22 more
Locations
  • City of Hope Duarte, California, United States
  • Stanford Cancer Institute (SCI) Stanford, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Mayo Clinic Jacksonville, Florida, United States
View all 40 locations
View Trial Details
Completed

Phase 1/2, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis

NCT01707264

Conditions
Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +10 more
Locations
  • Stanford University Cancer Center Palo Alto, California, United States
  • Tufts Medical Center Boston, Massachusetts, United States
  • Boston University School of Medicine Boston, Massachusetts, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details
Completed

S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis

NCT00064337

Conditions
Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • University of California Davis Cancer Center Sacramento, California, United States
  • Mountain States Tumor Institute at St. Luke's Regional Medical Center Boise, Idaho, United States
  • Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center Kansas City, Kansas, United States
View all 35 locations
View Trial Details

Related conditions